Pyrrolopyrazinyl urea kinase inhibitors
US8012974B2 · kind B2 · utility
2Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2009 |
| Grant date | Sep 6, 2011 |
| Priority date | — |
| Expiry date | Dec 3, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of novel pyrrolopyrazinyl urea derivatives of Formula I,wherein the variables R1, R2, R3, R4, and R5 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.